TDOC

Healthcare

Teladoc Health, Inc. · Medical - Healthcare Information Services · $1B

UQS Score — Balanced Preset
33.4
Below Average

Teladoc Health, Inc. scores 33.4/100 using the Balanced preset.

UQS vs Healthcare Sector
TDOC
33.4
Sector avg
32.4
Quality
Weak
Moat
Weak
Growth
Weak
Risk
Weak
Valuation
Neutral

TDOC Price History

-96.0% over 5Y

Monthly close, adjusted for stock splits and dividend reinvestment.

Return Calculator

What if I invested in Teladoc Health, Inc.?

$
Today it would be worth
$332
That's a -96.7% total return, or -49.4% annualized.

Based on Teladoc Health, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

Unlock Full TDOC Analysis

Sign in to unlock the detailed analysis behind the UQS Score.

  • Detailed 6-pillar UQS breakdown with exact scores
  • All 29 metrics with sector-calibrated comparisons
  • 6 investor presets (Buffett, Munger, Lynch, Wood, Graham, Balanced)
  • Watchlist tracking with score alerts
  • AI-generated investment perspectives across 6 preset views
  • Score history chart with change notifications
Analyze TDOC in Detail →

Pro Analysis

TDOC — Score History

2530354045Apr 2Apr 12Apr 22May 2May 12May 22May 24v5
Score changes· 4 most recent
DateUQSQualityMoatGrowthRiskValueChange
May 9, 202633.533.325.023.738.755.6+0.1
May 2, 202633.433.325.023.837.955.6+0.1
Apr 18, 202633.333.325.023.737.955.6-6.7
Apr 2, 202640.033.325.023.737.9100.0

TDOC — Pillar Breakdown

Quality

33.3/100 (25%)

Teladoc Health, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.

Capital Efficiency (ROIC)Weak

How effectively capital is deployed to generate returns.

Return on EquityWeak

Profitability relative to shareholders' equity.

Operating ProfitabilityWeak

Ability to convert revenue into operating profit.

Net ProfitabilityWeak

Bottom-line profit as a share of revenue.

Gross Profit / AssetsStrong

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationStrong

Free cash flow relative to market value.

Growth

23.6/100 (20%)

Teladoc Health, Inc. faces growth headwinds with declining or stagnant revenue trends.

Recent Revenue TrendWeak

Revenue trajectory over the last twelve months.

3Y Revenue CAGRWeak

Compound annual revenue growth rate over 3 years.

EPS GrowthStrong

Year-over-year earnings per share growth.

Forward Revenue OutlookWeak

Analyst consensus for future revenue growth.

Risk

38.7/100 (15%)

Teladoc Health, Inc. has some risk factors including moderate leverage or solvency concerns.

Financial LeverageWeak

Debt levels relative to earnings capacity.

Debt/EquityStrong

Total debt relative to shareholder equity.

Current RatioStrong

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

Valuation

55.6/100 (15%)

Teladoc Health, Inc. trades at a reasonable valuation with decent earnings yield and FCF multiples.

Price to Free Cash FlowStrong

How many years of FCF the market cap represents.

EV/EBITDA vs SectorWeak

Enterprise value multiple relative to sector median.

Moat

25/100 (25%)

Teladoc Health, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for TDOC.

Score Composition

Quality
33.3×25%8.3
Growth
23.6×20%4.7
Risk
38.7×15%5.8
Valuation
55.6×15%8.3
Moat
25.0×25%6.3
Total
33.4Below Average

Financial Data

More Stock Analysis

How is the TDOC UQS Score Calculated?

The UQS (Unified Quality Score) for Teladoc Health, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Teladoc Health, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Teladoc Health, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.